Clinical Trials
136 trialsFollow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
National Institutes of Health Clinical Center (CC)
Collection of Blood From Patients With Cancer
National Institutes of Health Clinical Center (CC)
DP-04
AstraZeneca
Trop2-targeted immunoPET Imaging of Solid Tumors
RenJi Hospital
DISRUPT
Icahn School of Medicine at Mount Sinai
LEARN
University of Sydney
OvAR-Y
Washington University School of Medicine
Brodalumab in the Treatment of Immune-Related Adverse Events
Columbia University
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
ModeX Therapeutics, An OPKO Health Company
iCaRe2
University of Nebraska
ELEPHAS-02
Elephas
CER
Cancer Support Community, Research and Training Institute, Philadelphia
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
Exscientia AI Limited
Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
Baylor College of Medicine
(CLOCS-2)
Imperial College London
Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors
Baylor College of Medicine
MOMENTUM
UMC Utrecht
ONE TEAM
Duke University
A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
Pilatus Biosciences Inc
SELECT-CAR-NK
Essen Biotech
EBNK-ST-001
Essen Biotech
IMPACT
Seattle Children's Hospital
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Angiex, Inc.
A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
Baylor College of Medicine
SCORE
Natera, Inc.
SL-28 for Advanced Solid Tumours
Second Life Therapeutics
ELEPHAS-05
Elephas
Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging
UNC Lineberger Comprehensive Cancer Center
Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology
Palo Alto Veterans Institute for Research
Comparison of the Diagnosis Time of VET and SCL in Patients With Intraoperative Coagulopathy
Konkuk University Medical Center
Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors
University Health Network, Toronto
Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors
Coherus Oncology, Inc.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
AYAConnect
UNC Lineberger Comprehensive Cancer Center
A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors
MacroGenics
A Comparison of Methods for Assisting Needle Angle Selection During Image-guided Tissue Biopsy
National Institutes of Health Clinical Center (CC)
EARN
Washington University School of Medicine
DELFI-L101
Delfi Diagnostics Inc.
JUMP
Brigham and Women's Hospital
Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies
Novita Pharmaceuticals, Inc.
(3D) Ultrasound Imaging Liver and Kidney
Western University, Canada
A Study of CDX-585 in Patients With Advanced Malignancies
Celldex Therapeutics
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
INSPIRE
Singlera Genomics Inc.
RespEcran
Centre Georges Francois Leclerc
FUTURE
Assistance Publique Hopitaux De Marseille
Proteomic Analysis of Patients Undergoing Bariatric Surgery
Universidade Federal de Pernambuco
Perioperative Myocardial and Renal Injury in Patients Undergoing Hepatic Resection
Istanbul Saglik Bilimleri University